Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
2024 · Targeted Oncology · 5 citations
https://doi.org/10.1007/s11523-024-01039-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
140
Citations
7
h-index
5
i10-index
Haoguang Chen is an academic researcher from First Affiliated Hospital Zhejiang University. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Advanced Decision-Making Techniques & Adaptive Control of Nonlinear Systems. The author has an h-index of 7, co-authored 29 publications.
https://doi.org/10.1007/s11523-024-01039-y
https://doi.org/10.1159/000538479
https://doi.org/10.1016/s2152-2650(25)03739-5
Click to start Chat